Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.

Abstract

PURPOSE We previously described a novel breast cancer staging system for assessing prognosis after neoadjuvant chemotherapy on the basis of pretreatment clinical stage (CS), estrogen receptor status (E), grade (G), and post-treatment pathologic stage (PS). This clinical-pathologic stage (CPS) + EG staging system assigned and summed points for each factor… (More)
DOI: 10.1200/JCO.2010.31.8469

Topics

6 Figures and Tables

Cite this paper

@article{Mittendorf2011ValidationOA, title={Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.}, author={Elizabeth A Mittendorf and Jacqueline Sara Jeruss and S. Tucker and Aparna H Kolli and Lisa Ann Newman and Ana Mar{\'i}a Gonz{\'a}lez-Angulo and T. Buchholz and Aysegul A. Sahin and Janice N. Cormier and Aman U. Buzdar and Gabriel N Hortobagyi and Kelly K. Hunt}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 15}, pages={1956-62} }